Qiming Venture Partners — 2015 Investments
2 investments dated 2015 · listed companies and verified rows first · show all
Schrödinger develops a physics-based computational platform for discovering and optimizing molecules, used to accelerate drug discovery and materials design.
AI & Machine LearningBiotechDeep TechNew MaterialsNew York, US
Richard Friesner(Director)Ramy Farid(Executive Officer, Director)Murco Ringnalda(Executive Officer)
BoardCharles Ardai(Director)Joshua Distler(Director)Timothy Wright(Director)
Austin, US
Brian Magierski(Executive Officer, Director, Promoter)Steve Papermaster(Executive Officer, Director, Promoter)
Board seatGary Rieschel· per SEC Form D
Co-investorsTrue VenturesWestern Technology Investment
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.